|
Volumn 38, Issue 2, 2000, Pages 200-208
|
Enhancing effect of patented whey protein isolate (Immunocal) on cytotoxicity of an anticancer drug
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BAICALEIN;
GLUTATHIONE;
IMMUNOCAL;
PHOSPHATIDYLSERINE;
UNCLASSIFIED DRUG;
VEGETABLE PROTEIN;
ANTIOXIDANT;
FLAVANONE DERIVATIVE;
FLAVONOID;
MILK PROTEIN;
WHEY PROTEIN;
APOPTOSIS;
ARTICLE;
CANCER ADJUVANT THERAPY;
CELL GROWTH;
CELL SURVIVAL;
CONTROLLED STUDY;
DRUG CYTOTOXICITY;
DRUG POTENTIATION;
HEPATOMA CELL;
HUMAN;
HUMAN CELL;
MEMBRANE POTENTIAL;
MITOCHONDRIAL MEMBRANE;
PATENT;
WHEY;
ADJUVANT CHEMOTHERAPY;
CELL CULTURE;
CELL MEMBRANE POTENTIAL;
CULTURE MEDIUM;
DRUG EFFECT;
FLOW CYTOMETRY;
KINETICS;
ANTINEOPLASTIC AGENTS;
ANTIOXIDANTS;
APOPTOSIS;
CELL SURVIVAL;
CHEMOTHERAPY, ADJUVANT;
CULTURE MEDIA;
DRUG SYNERGISM;
FLAVANONES;
FLAVONOIDS;
FLOW CYTOMETRY;
GLUTATHIONE;
HUMANS;
KINETICS;
MEMBRANE POTENTIALS;
MILK PROTEINS;
TUMOR CELLS, CULTURED;
|
EID: 0034351133
PISSN: 01635581
EISSN: None
Source Type: Journal
DOI: 10.1207/S15327914NC382_9 Document Type: Article |
Times cited : (31)
|
References (51)
|